Vistagen Therapeutics Inc. (VTGN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Vistagen Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.17
−2.30% today
Market cap
$8M
Overall quality
—
Kronos AI 30-day
—
Vistagen Therapeutics Inc. (VTGN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $8M. It trades at $0.17, down 2.30% today.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.